|
 |
|||||
| home : pages : what's new in medicine vol. 4 : fda approves genetic tests for breast cancer ... : | |||||
|
|
 |
FDA APPROVES GENETIC TESTS FOR BREAST CANCERThe FDA has recently approved a gene-based test that may help to predict the recurrence of breast cancer. The test detects levels of Her2/neu, a gene on chromosome 17, which is amplified in a subset of breast cancer. The test will be manufactured by Oncar under the name Inform and is expected to be commercially available at a cost of about $200. This is the first time a gene-based test for cancer has been approved. About 180,000 women in the U.S. are diagnosed with breast cancer annually and 44,000 die of the disease each year. About a third of breast cancers test positive for amplification of the Her2/neu gene.--> return to menu / back ... (click) --> return to top of the page (click) |
|||
 |
| (T) 212.439.1958 | 14 East 69th St, New York, NY 10021 | (F) 212.439.6718 |
| 2000-2008 © Mary Wilson M.D., P.C. All rights reserved. | ||
| Site Designed & Maintained by Delamain IT Web Design & SEO. |